Feasibility indicator | Middle Group (2011–2013)a | Late Group (2018–2020)a | ||||
---|---|---|---|---|---|---|
N=200 | N=200 | |||||
Odds ratio | 95% CIb | p-value | Odds ratio | 95% CIb | p-value | |
Recruitment | 1.18 | 0.77, 1.79 | 0.450 | 1.60 | 1.03, 2.49 | 0.036 |
Retentionc | 1.51 | 0.25, 9.1 | 0.655 | - | - | Â |
Acceptability | ||||||
 Description of quantitative measure | 1.49 | 0.95, 2.35 | 0.085 | 3.05 | 1.97, 4.72 | <0.001 |
 Quantitative outcome | 1.53 | 0.99, 2.35 | 0.051 | 2.68 | 1.76, 4.08 | <0.001 |
 Description of qualitative measure | 1.57 | 0.93, 2.63 | 0.090 | 3.32 | 2.04, 5.40 | <0.001 |
 Qualitative outcome | 1.23 | 0.76, 1.99 | 0.393 | 2.32 | 1.48, 3.65 | <0.001 |
Attendance | ||||||
 Description of measure | 1.16 | 0.68, 1.96 | 0.590 | 1.49 | 0.89, 2.49 | 0.124 |
 Outcome | 1.14 | 0.76, 1.73 | 0.527 | 0.96 | 0.63, 1.45 | 0.830 |
Compliance | ||||||
 Description of measure | 1.36 | 0.85, 2.17 | 0.194 | 2.04 | 1.30, 3.20 | 0.002 |
 Outcome | 1.20 | 0.77, 1.88 | 0.424 | 2.29 | 1.49, 3.52 | <0.001 |
 Cost | 0.62 | 0.19,1.91 | 0.261 | 1.26 | 0.49,3.27 | 0.193 |
Treatment fidelity | ||||||
 Description of measure | 1.96 | 1.11, 3.45 | 0.019 | 2.56 | 1.48, 4.42 | 0.001 |
 Outcome | 1.16 | 0.62, 2.16 | 0.635 | 2.13 | 1.21, 3.77 | 0.009 |
 Mentioned feasibility-related parameters in purpose statement | 1.38 | 0.93, 2.05 | 0.109 | 2.38 | 1.58, 3.61 | <0.001 |
 Cited a guideline/framework for the reporting of preliminary studies | 5.76 | 1.26, 26.3 | 0.024 | 28.74 | 6.87, 120.3 | <0.001 |